Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Prolactin and TGF-β receptor blockers might help treat hair loss.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Children under 10 can experience hair thinning without hormone issues, and it may improve with treatment.

Coffee and tea might help hair growth in balding individuals, but side effects and alternative uses are being considered.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Androgens can cause hair growth in some areas and hair loss on the scalp.